To amend title XVIII of the Social Security Act to improve Medicare beneficiary access to new medical technologies that improve health care quality and outcomes by ensuring that breakthrough devices are eligible for conditional approval under the Medicare New Technology Add-On Payment (NTAP) Program, enabling these medical breakthroughs to be provided to Medicare beneficiaries without unnecessary delay.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill expands conditional approval for breakthrough devices under Medicare NTAP program. It relies on reimbursement change, eligibility expansion, and regulatory streamline. The main policy areas are Healthcare.
Who Benefits and How
Medical Device Manufacturers (Breakthrough Devices) could gain revenue opportunities, Medicare Beneficiaries (Patients) would be affected, and Hospitals (Inpatient Facilities) could gain revenue opportunities.
Who Bears the Burden and How
Competing Medical Device Manufacturers would be affected.
Key Provisions
- Expands conditional approval for breakthrough devices under Medicare NTAP program.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill expands conditional approval for breakthrough devices under Medicare NTAP program.
Key Policy Areas
Healthcare
Primary Purpose
The bill expands conditional approval for breakthrough devices under Medicare NTAP program.
Policy Domains
Whole bill
Identified Gains
- Medical Device Manufacturers (Breakthrough Devices)
- Medicare Beneficiaries (Patients)
- Hospitals (Inpatient Facilities)
Identified Costs
- Competing Medical Device Manufacturers
Sponsors
Mike Carey
R-OH | Primary Sponsor
Legislative Progress
IntroducedMr. Carey (for himself and Mr. Davis of Illinois) introduced …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Hospitals (Inpatient Facilities), Medical Device Manufacturers (Breakthrough Devices)
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology